Amgen, the giant biotech company based in Thousand Oaks, saw its shares drop 2 percent to $149.23 on Sept. 3 after its rival Novartis launched a drug similar to Amgen’s that costs 15 percent less. Novartis’ Zarxio and Amgen’s Neupogen both help chemotherapy patients battle infections by increasing the production of white blood cells. The Read More →
Sientra, a Goleta-based breast implant manufacturer, submitted documents to the Securities and Exchange Commission to offer an additional $75 million worth of stock on Sept. 3. Sientra raised about $77 million after paying underwriting expenses when it started trading on the Nasdaq on Oct. 29, 2014. At the time, the company said it sold 5.75 Read More →
The combined American Riviera Bank and The Bank of Santa Barbara will be known as American Riviera Bank, the merged institution announced Aug. 27. Santa Barbara-based marketing agency Idea Engineering deemed that the name would have better “brand impact.” The banks proposed the merger in July, which would combine two smaller companies into a three-branch Read More →
Thousand Oaks-based biotech giant Amgen won U.S. approval for its powerful cholesterol-lowering drug Repatha for certain patients, making it the second in a new class of treatments to come to market, Bloomberg News reported Aug. 27. The Food and Drug Administration cleared Repatha for people with hard-to-treat levels of bad cholesterol, according to a statement Read More →
Goleta-based Community West Bancshares, parent company of Community West Bank, reported a loss of $2.3 million in the second quarter of 2015 following a $7.2 million loan settlement. The company recorded a profit of $1.7 million in the same period last year. “Community West’s second quarter results included solid loan and deposit growth and strong Read More →
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.